Immunity Theme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A landmark trial in The Gambia found the patches - which painlessly penetrate the skin - were just as effective as injections against measles and rubella.

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that painlessly penetrate the skin and deliver the vaccine, or by conventional injection with a needle and syringe.

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses.The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that painlessly penetrate the skin and deliver the vaccine, or by conventional injection with a needle and syringe.

The rollout of Men5CV, a 5-in-1 vaccine to protect against five strains of meningitis, has started in Nigeria, according to an announcement made by the World Health Organization (WHO).Meningitis is a serious infection that leads to inflammation of the membranes that surround and protect the brain and spinal cord. Although research has shown that the disease is largely preventable with proper vaccination, last year there was a 50% jump in annual meningitis cases reported across Africa.

Roy Robins-Browne’s profile on The Conversation